Kernal Biologics, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Kernal Biologics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2022.
Kernal Biologics at a glance
What does Kernal Biologics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $20.1 million sold (2022).
Frequently asked questions about Kernal Biologics
Where is Kernal Biologics headquartered?
Kernal Biologics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Kernal Biologics do?
Kernal Biologics, Inc. is a biotechnology company.
When was Kernal Biologics founded?
The earliest incorporation on record for Kernal Biologics, Inc. is in 2016, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences